ESAB
Earnings company data as of 4:46 AM ET 10/24
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 1.32 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by ESAB's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $414K sold by 2 insiders outside a trading plan
- $8.4M sold by 3 insiders under 10b5-1 plans
-
Rhonda L Jordan DirectorSale$95K 1,000 shares at $95.00 100% of stakeTraded Aug 7 Filed Aug 10
-
Michele Campion Chief Human Resources OfficerPlanned sale$625K 5,096 shares at $122.63 31% of stakeTraded Feb 27 Filed Mar 2
-
Shyam Kambeyanda CEOPlanned sale$7.4M 59,404 shares at $123.79 37% of stakeTraded Feb 23 Filed Feb 25
-
Kevin J Johnson CFOPlanned sale$470K 3,494 shares at $134.62 12% of stakeTraded Feb 6 Filed Feb 9
-
Rajiv Vinnakota DirectorSale$319K 2,783 shares at $114.50 24% of stakeTraded Nov 11, 2025 Filed Nov 13, 2025
Also filed in the last 12 months, not counted as buying or selling: 35 option exercises, 33 share withholdings for taxes, 10 stock grants, 3 gifts, and 2 other transactions.
SEC filings
Recent issuer filings from EDGAR, 11 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K/A | 9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 424B7 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 2.01,3.02,3.03,5.03,7.01,8.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.